China NMPA Product Recall - Patient monitor

GE Healthcare Finland Oy initiated a voluntary recall of specific patient monitors due to a critical software anomaly. The issue pertains to the Patient Data Module (PDM) software version V2.6 when combined with host software version V2.0.7 or earlier on patient monitor models B8850, B650, and B450. This specific configuration fails to generate essential visual and auditory apnea alarms during an apnea event, incorrectly displaying the respiratory rate instead. Such a defect could potentially delay critical intervention for patients experiencing apnea. While the recall addresses a significant patient safety concern, GE Healthcare Systems Trading Development (Shanghai) Co., Ltd. reported to China's National Medical Products Administration (NMPA) that the affected products were not distributed within the Chinese market, making the recall 'not applicable' to China for sales and usage. The recall, formally reported on August 8, 2017, and published by the NMPA on September 26, 2017, targets affected regions including the European Economic Area and the United States. No patient injuries have been reported directly related to this software issue. The regulatory framework underscores the NMPA's role in overseeing medical device safety, even when products are not domestically sold.